Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
137 participants
INTERVENTIONAL
2023-10-06
2024-09-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Systane® Complete Preservative Free Lubricant Eye Drops
NCT05932225
Systane® Ultra Preservative Free Lubricant Eye Drops
NCT05902364
SYSTANE® BALANCE Symptoms (OSDI) & Inflammatory Biomarkers
NCT01733732
Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface Staining
NCT01863368
Evaluation of SYSTANE Ultra Lubricant Eye Drops
NCT00702377
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Systane Hydration Preservative Free (PF)
1-2 drops in each eye four times a day for 30 days
Polyethylene glycol 400 and propylene glycol solution/drops - Preservative Free (PF)
commercially available eye drops
Systane Hydration Preserved
1-2 drops in each eye four times a day for 30 days
Polyethylene glycol 400 and propylene glycol solution/drops - Preserved
commercially available eye drops
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Polyethylene glycol 400 and propylene glycol solution/drops - Preservative Free (PF)
commercially available eye drops
Polyethylene glycol 400 and propylene glycol solution/drops - Preserved
commercially available eye drops
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject with mild to moderate dry eye
* Subject with CL-related dry eye symptoms
Exclusion Criteria
* Has undergone any other ocular surgery (including intraocular surgery) within the past 6 months or has any ocular surgery planned during the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Lead, Vision Care
Role: STUDY_DIRECTOR
Alcon Research, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Integra Eye Care
Burnaby, British Columbia, Canada
Aggarwal and Associates Limited
Brampton, Ontario, Canada
University of Waterloo School of Optometry
Waterloo, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DEN923-I001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.